YTHDF3 and cervical cancer: In addition, survival analysis showed that cervical cancer patients with increased expression of METTL3 (Figure 7I), YTHDF3 (Figure 7J), and HDAC6 (Figure 7K) represented an obviously unsatisfied overall survival (OS).